News
Emcure Pharmaceuticals consolidated net profit rises 25.13% in the September 2025 quarter
11-Nov-2025 | 16:05
Sales rise 13.38% to Rs 2269.82 crore
Net profit of Emcure Pharmaceuticals rose 25.13% to Rs 243.46 crore in the quarter ended September 2025 as against Rs 194.57 crore during the previous quarter ended September 2024. Sales rose 13.38% to Rs 2269.82 crore in the quarter ended September 2025 as against Rs 2001.98 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 2269.82 | 2001.98 | 13 |
| OPM % | 20.95 | 19.03 | - |
| PBDT | 446.06 | 370.31 | 20 |
| PBT | 341.42 | 273.41 | 25 |
| NP | 243.46 | 194.57 | 25 |
Powered by Capital Market - Live News